|
Medical News -
Litigation and Medical Malpractice
|
|
Merck & Co., Inc. reported that it has received a letter from the U.S. Attorney's Office for the District of Massachusetts advising the company that it is a target of a previously-disclosed federal grand jury investigation. The investigation relates to activities in connection with VIOXX, a medicine that Merck voluntarily withdrew from the market in 2004. The company has previously disclosed the government's investigation, which has been ongoing since 2004, in various filings with the U. S. Read more:
|
